Table 1: Characteristics of patients with NSCLC.
| No. of patients | 56 |
| Patients age (years) | 53.4 (range: 45-76 years) |
| Male no. (%) Female no. (%) |
35 (62.5%) 21 (37.5%) |
| Stage IV | 56 (100%) |
| Confirmation of diagnosis with liver biopsie | 56 (100%) |
| TACE with mitomycin and gemcitabine and cisplatin | 56 (100%) |
| Localisation in liver: Bilobar Right lobar Left lobe | 38 (67.9%) 18 (32.1%) 0 (0%) |
| Number of tumor lesions: 1 2 3+4 Multiple |
7 (12.5%) 9 (16.1%) 6 (10.7%) 34 (60.7%) |
| Tumor vascularity: Hypervascular Hypovascular |
22 (39.3%) 34 (60.7%) |
| Tumor response: Partial response Stable disease Progressive disease |
8 (14.3%) 29 (51.8%) 19 (33.9%) |